Lercanidipine is a dihydropyridine calcium channel blocker used for the management of hypertension. It causes vasodilation by inhibiting the influx of calcium ions into vascular smooth muscle. Lercanidipine has a slow onset and long duration of action, minimizing blood pressure variability. It is generally well tolerated, with headache and ankle swelling being the most common side effects.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Letermovir and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Letermovir impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Letermovir-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
-Letermovir Ethyl Ester.jpg)
